Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Century Therapeutics, Inc.
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 09, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 23, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
April 11, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
April 08, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
March 14, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
December 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
December 06, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
December 06, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition
November 02, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
September 26, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
April 17, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Leadership Changes
April 12, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates
March 16, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the AACR Annual Meeting 2023
March 15, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 21, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas
February 08, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 01, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026
January 05, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit